We aimed to test the hypothesis that the immune-modulatory effect of statins may improve survival outcomes in patients with non-muscle invasive bladder cancer (NMIBC). We focused on a cohort of patients diagnosed with high risk NMIBC, that were treated with intravesical BCG immunotherapy.
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study / M. Ferro, M. Marchioni, G. Lucarelli, V.M. Dorin, F. Soria, D. Terracciano, F.A. Mistretta, S. Luzzago, C. Buonerba, F. Cantiello, A. Mari, A. Minervini, A. Veccia, A. Antonelli, G. Musi, R. Hurle, G.M. Busetto, F. Del Giudice, B.I. Chung, F. Berardinelli, S. Perdonà, P. Del Prete, V. Mirone, M. Borghesi, A. Porreca, P. Bove, R. Autorino, N. Crisan, A.R. Abu Farhan, M. Battaglia, P. Ditonno, G.I. Russo, M. Muto, R. Damiano, M. Manfredi, F. Porpiglia, O. De Cobelli, L. Schips. - In: MINERVA UROLOGY AND NEPHROLOGY. - ISSN 2724-6051. - 73:6(2021 Jan 13), pp. 796-802. [10.23736/S0393-2249.20.04076-X]
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study
F.A. Mistretta;S. Luzzago;A. Antonelli;G. Musi;M. Muto;O. De Cobelli;
2021
Abstract
We aimed to test the hypothesis that the immune-modulatory effect of statins may improve survival outcomes in patients with non-muscle invasive bladder cancer (NMIBC). We focused on a cohort of patients diagnosed with high risk NMIBC, that were treated with intravesical BCG immunotherapy.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Association of statin use.pdf
accesso riservato
Descrizione: Original Article
Tipologia:
Publisher's version/PDF
Dimensione
412.06 kB
Formato
Adobe PDF
|
412.06 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
